← Leaderboards
Ralph J. Jensen
Va Boston Health Care System
$0
Attributed
$0
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2011–17$1$1$1$0$0
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
VA$0 · 2
By mechanism
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Va Boston Health Care System
Same institution · by research overlap
- Shawn K. Kelly$0
- Douglas B. Shire$203,541
Others in their field
Top investigators on “Retinitis Pigmentosa”
- Keri Hammel · The Emmes Company, Llc$46,456,947
- Krzysztof Palczewski · University Of California-Irvine$33,155,003
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Martin Friedlander · Scripps Research Institute$20,871,116
- Robert Jay Greenberg · Second Sight Medical Products, Inc.$17,690,386
- Gustavo David Aguirre · University Of Pennsylvania$17,591,050
Research focus
Retinitis PigmentosaRetinalRattusRetinal ProsthesisVisualRetinal DegenerationLightPropertyRetinaRetinal Ganglion CellsPhotoreceptorsVisionPhotoreceptor DegenerationAnimal ModelAge Related Macular DegenerationImplantBlindnessOutputResponseNeuronsDegenerative DisorderAffectCellsPharmacotherapy
Grant awards (7)
Pharmacotherapy for Retinal Degenerative Disorders$0
I01 · FY2017 · VA · contact PI
Pharmacotherapy for Retinal Degenerative Disorders$0
I01 · FY2016 · VA · contact PI
Pharmacotherapy for Retinal Degenerative Disorders$0
I01 · FY2015 · VA · contact PI
Pharmacotherapy for Retinal Degenerative Disorders$0
I01 · FY2015 · VA · contact PI
Stimulation Thresholds of Ganglion Cells in the Degenerate Retina$0
I01 · FY2014 · VA · contact PI
Stimulation Thresholds of Ganglion Cells in the Degenerate Retina$0
I01 · FY2014 · VA · contact PI
Stimulation Thresholds of Ganglion Cells in the Degenerate Retina$0
I01 · FY2011 · VA · contact PI